-
Mashup Score: 5Peru: Increase in cases of Guillain Barré syndrome declared an emergency - Outbreak News Today - 10 month(s) ago
NewsDesk @bactiman63 Due to the unusual increase in cases of Guillain Barré syndrome (GBS), the Peru Government declared a national health emergency for a period of 90 calendar days, reported the minister of Health, César Vásquez. “So far we have controlled the disease. Guillain Barré appears every year and there has been a significant increase in recent […]
Source: Outbreak News TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 11
Background and Objectives Infections play a key role in the development of Guillain-Barré syndrome (GBS) and have been associated with specific clinical features and disease severity. The clinical variation of GBS across geographical regions has been suggested to be related to differences in the distribution of preceding infections, but this has not been studied on a large scale. Methods We…
Source: NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 4Patient Assistance Programs, Medication Specific Assistance Programs - NORD (National Organization for Rare Disorders) - 2 year(s) ago
Information about NORD Patient Assistance Programs and Medication Specific Assistance Programs.
Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 11Current issue: Trends in Immunology - 2 year(s) ago
Developing cultural humility in immunology and STEMM mentoringCultural humility allows a better understanding and appreciation of others, as well as fostering positive interactions with different kinds of individuals. Here, we discuss the difficulties faced by persons excluded because of their ethnicity or race (PEERs) in immunology and science, technology, engineering, mathematics, and medicine…
Source: www.cell.comCategories: Allergy-Immunology, Latest HeadlinesTweet-
Check out @TrendsImmuno April issue! #NAD in #COVID19, #Tfh survival, #GuillainBarre & #mimicry, #BCG #vaccination & #crossprotection, #odorant #receptors, old #macrophages, #LongCovid, #SARSCoV2 #vaccination, #TLS, #magnesium for #Tcells, #ICOS & more! https://t.co/uMv3atEBoQ https://t.co/qoy6EZF62Q
-
-
Mashup Score: 28
Based on the Vaccine Adverse Event Reporting System, this article reports on the prevalence of presumptive Guillain-Barré syndrome among recipients of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 5
Based on the Vaccine Adverse Event Reporting System, this article reports on the prevalence of presumptive Guillain-Barré syndrome among recipients of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine.
Source: jamanetwork.comCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 5CDC Panel Updates Info on Rare Side Effect After J&J Vaccine - 3 year(s) ago
The ACIP discussed slightly higher rates of the rare side effect of Guillain-Barré syndrome after the J&J vaccine, and presented reaffirming evidence of the vaccine’s effectiveness against variants.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 1
The FDA has said that Johnson & Johnson’s COVID-19 vaccine may lead to an increased risk for Guillain-Barré syndrome.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
The FDA has updated the fact sheet for the Janssen COVID-19 vaccine to include information related to an increased risk of Guillain-Barré syndrome.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
The FDA has said that Johnson & Johnson’s COVID-19 vaccine may lead to an increased risk for Guillain-Barré syndrome.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
RT @bactiman63: #Peru: Increase in cases of #GuillainBarré syndrome declared an emergency https://t.co/BySUTJW8u8